Bibliografia - 1ª Parte

1. ANONYMOUS. FDA investigating IUDs after deaths reported. FDA Drug Bulletin 4(2): 10. 1974.

2. ACADEMIA NACIONAL DE MEDICINA (ANM). Respuestas de la Academia Nacional de Medicina al Ministerio de Salud sobre "dispositivos intrauterinos." [Responses of the National Academy of Medicine to the Ministry of Health on "Intrauterine Devices."][SPA] Bogotá, Colombia, ANM, Sep. 1986. 1 p.

3. ALAN GUTTMACHER INSTITUTE (AGI). Risky business: an overview of the crisis in liability insurance. Washington, D.C., AGI, Dec. 1986. 37 p.

4. ALVIOR, G.T., Jr. Pregnancy outcome with removal of intrauterine device. Obstetrics and Gynaecology 41(6): 894–896. Jun. 1973.

5. ALZA CORPORATION (AC). The Progestasert: intrauterine progesterone contraceptive system: release rated 65 mg/day progesterone for one year. Palo Alto, California, AC, 1976. 61 p.

6. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS (ACOG). ACOG’s statement on Searle’s removal of IUDs. Washington, D.C., ACOG, Jan. 31, 1986. 1 p. (Mimeo)

7. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS (ACOG). The intrauterine device. ACOG Technical Bulletin No. 104, May 1987. 5 p.

8. AMERICAN PUBLIC HEALTH ASSOCIATION. APHA passes 22 new policies; calls for death penalty ban, opposes Contra aid. The Nation’s Health 16(10–11): 7. Oct.-Nov. 1986.

9. ANDOLSEK, L., TEETER, R.A., KOZUH-NOVAK, M., WHEELER, R., FORTNEY, J.A., and ROSENBERG, M.J. Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory disease and age. International Journal of Gynaecology and Obstetrics 24(3): 217–223. Jun. 1986.

* 10. ANDRADE, A.T.L. and PIZARRO, E.P. Quantitative studies on menstrual blood loss in IUD users. Contraception 36(1): 129–144. Jul. 1987.

11. ANN, T.B. and SIM, C.C. Knowledge and use of contraception. [Draft] Kuala Lumpur, Malaysia, National Population and Family Development Board, 1987. 32 p.

12. AREF, I., HEFNAWI, F., KANDIL, O., YACOUT, M., and SAID, E. Effect of ML Cu250 IUD on menstrual blood loss and sperm migration. In: Hafez, E.S.E. and Van Os, W.A.A., eds. Medicated IUDs and polymeric delivery systems. Detroit, Hafez and Van Os, 1979. p. 22A–22B.

13. ASOCIACION DEMOGRAFICA SALVADORENA. and INSTITUTE FOR RESOURCE DEVELOPMENT, WESTINGHOUSE. El Salvador National Family Health Survey, 1985. Jan. 1987. 23 p. (Unpublished)

14. AUDEBERT, A.J.M. Follow-up studies of the new IUD "Ombrelle 250." Advances in Contraception 3(3): 192–193. Sep. 1987.

15. AUDEBERT, A.J.M. and EMPERAIRE, J.C. Pelvic and abdominal IUDs: pathophysiology, diagnosis and management. In: Hafez, E.S.E. and Van Os, W.A.A., eds. IUD pathology and management. Boston, G.K. Hall, 1980. (Progress in Contraceptive Delivery Systems Vol. 3) p. 159–168.

16. AUDEBERT, A.J.M., EMPERAIRE, J.C., LARUE-CHARLUS, S., and VAN DER PAS, H. Clinical performance of the Ombrelle 250—a new copper IUD. In: Zatuchni, G.I., Goldsmith, A., and Sciarra, J.J., eds. Intrauterine contraception: advances and future prospects. Philadelphia, Harper & Row, 1985. p. 263–265.

17. AZNAR, R., REYNOSO, L., MONTEMAYOR, G., and GINER, J. Post-placental insertion of IUDs. Contraceptive Delivery Systems 1(2): 143–148. Apr. 1980.

18. BAKER, J. Contraceptive safety research in Asia: a literature review. Bangkok, Population Council, Aug. 1983. 113 p.

19. BANHARNSUPAWAT, L. and ROSENFIELD, A.G. Immediate postpartum IUD insertion. Obstetrics and Gynecology 38(2): 276–285. Aug. 1971.

20. BATAR, I. Fertility after IUD removal. In: Hafez, E.S.E. and Van Os, W.A.A., eds. Medicated intrauterine devices: physiological and clinical aspects. The Hague, Netherlands, Martinus Nijhoff, 1980. p. 159–168.

21. BATÁR, I. Clinical experience with the MLCu250 IUD (eight-year results). Advances in Contraception 1(4): 329–335. Dec. 1985.

22. BEERTHUIZEN, R.J.C.M., VAN WIJCK, J.A.M., ESKES, T.K.A.B., VERMEULEN, A.H.M., and VOOIJS, G.P. Pathomorphologic changes in the oviducts in IUD patients. In: Hafez, E.S.E. and Van Os, W.A.A., eds. Medicated IUDs and polymeric delivery systems. Detroit, Hafez and Van Os, 1979. p. 35A–35B.

23. BELHADJ, H., SIVIN, I., DIAZ, S., et. al. Recovery of fertility after use of the levonorgestrel 20 mg/d or Copper T 380 Ag intrauterine device. Contraception 34(3): 261–267. Sep. 1986.

24. BELL, T.A. and HOLMES, K.K. Age-specific risks of syphilis, gonorrhea, and hospitalized pelvic inflammatory disease in sexually experienced U.S. women. Sexually Transmitted Diseases 11(4): 291–295. Oct.-Dec. 1984.

25. BENSON, P. (PATH/PIACT) [Research on new IUDs] Personal communication, Oct. 16, 1987.

26. BERENT, J. Family planning in Europe and USA in the 1970s. Voorburg, Netherlands, International Statistical Institute, Oct. 1982. (World Fertility Survey Comparative Studies No. 20) 33 p.

27. BERNARD, R.P. IUD performance patterns—a 1970 world view. International Journal of Gynecology and Obstetrics 8(6, Pt. 2): 926–940. Nov. 1970.

28. BHATTACHARJEE, P.J., RAO, A.N., and GOWDA, H.B.S. A study of IUD retention in Karnataka. Population Centre Bangalore Newsletter 7(1): 1–7. Jan.-Mar. 1987.

29. BLACKBURN, B. (US Agency for International Development) [US AID IUD supplies, 1984–87] Personal communication, Jun. 1, 1987.

30. BLOUNT, J.H., REYNOLDS, G.H., and RICE, R.J. Pelvic inflammatory disease: incidence and trends in private practice. Morbidity and Mortality Weekly Report 32(4SS): 27SS–34SS. 1983.

31. BLUM, M. and PERY, J. Prevention of iron deficiency anemia in IUD users by prostaglandin synthetase inhibitors. Contraceptive Delivery Systems 5(1): 21–23. Jan. 1984.

32. BOGUE, D.J. and BOGUE, E.J. Comparative birth interval analysis. Chicago, University of Chicago, Community and Family Study Center, 1980. (Family Planning Research and Evaluation Manual No. 15) 129 p.

33. BOOTH, M., BERAL, V.A., and GUILLEBAUD, J. Effect of age on pelvic inflammatory disease in nulliparous women using a Copper 7 intrauterine contraceptive device. British Medical Journal 281(6233): 114. Jul. 12, 1980.

34. BOYD, E.F., Jr. and HOLMSTROM, E.G. Ovulation following therapeutic abortion. American Journal of Obstetrics and Gynecology 113(4): 469–473. Jun. 15, 1972.

35. BRASIL. CENTRO DE PESQUISAS DE ASSISTÊNCIA INTEGRADA À MU-LHER E À CRIANÇA (CPAIMC). IUD insertions by nursing personnel. Rio de Janeiro, CPAIMC, Aug. 1987. 21 p.

36. BRONNENKANT, L.J. (Finishing Enterprises, Inc.) [Lippes Loop specifications, instructions, sales] Personal communication, Sep. 16, 1987.

37. BROWN, G.F., JAIN, A.K., and GILL, J. Analysis of population policies and programs in India. New York, Population Council, Sep. 1987. 125 p.

38. BUCHMAN, M.I. A study of the intrauterine contraceptive device with and without an extracervical appendage or tail. Fertility and Sterility 21(4): 348–355. Apr. 1979.

39. BUDNICK, L.D. and PAKTER, J. Ectopic pregnancy in New York City, 1975–1980. American Journal of Public Health 72(6): 580–584. Jun. 1982.

40. BURKINA FASO. MINISTRY OF HEALTH (MOH). DEPARTMENT OF MATERNAL AND CHILD HEALTH. and COLUMBIA UNIVERSITY. CENTER FOR POPULATION AND FAMILY HEALTH (CPFH). Du projet de recherche operationnelle: consolidation des services de prestation sanitaire en direction de la famille au Burkina Faso. [Final report on operations research project: consolidation of health delivery services for the family in Burkina Faso.][FRE] Ougadougou, Burkina Faso and New York, MOH and CPFH, Dec. 1986. 96 p.

41. BURKMAN, R.T. and WOMEN’S HEALTH STUDY. Association between intrauterine device and pelvic inflammatory disease. Obstetrics and Gynecology 57(3): 269–276. Mar. 1981.

42. BURNHILL, M.S. Intrauterine contraception. In: Corson, S.L., Derman, R.J., and Tyrer, L.B., eds. Fertility control. Boston, Little, Brown and Company, 1985. p. 271–285.

43. CANADA. COMMITTEE ON THE OPERATION OF THE ABORTION LAW. Report of the Committee on the Operation of the Abortion Law. Ottawa, Minister of Supply and Services, Canada, 1977. 474 p.

44. CARRON, J.M., MELIAN, M.M., MONTHEITH, R.S., MORRIS, L., KINCHEN, S., and WARREN, C.W. Family planning survey: Paraguay 1987. Atlanta, Georgia, Centers for Disease Control, Feb. 1988. 121 p.

45. CASTADOT, M.-J., ROBINOWITZ, M., CHERVENAK, F.A., SEDLIS, A., and BORIA, M.C. Recognizing malignancy in intrauterine contraceptive device users. American Journal of Obstetrics and Gynecology 136(7): 966–967. Apr. 1, 1980.

46. CATES, W., Jr., ORY, H.W., ROCHAT, R.W., and TYLER, C.W., Jr. The intrauterine device and deaths from spontaneous abortion. New England Journal of Medicine 295(21): 1155–1159. Nov. 18, 1976.

47. CENTRO DE ESTUDIOS DE POBLACIÓN Y PATERNIDAD RESPONSABLE (CEPAR). and ECUADOR. INSTITUTO NACIONAL DE INVESTIGACIONES NUTRICIONALES Y MEDICO SOCIALES (ININMS). and INSTITUTE FOR RESOURCE DEVELOPMENT/WESTINGHOUSE (IRD/W). Ecuador Encuesta Nacional de Demografia y Salud Familiar. [Ecuador National Survey of Demography and Family Health.][SPA] [Quito], Ecuador, CEPAR and ININMS, and [Columbia, Maryland], IRD/W, 1987. 25 p.

48. CHAMPION, C. (Family Health International) [FHI’s IUD research program: ongoing studies and preliminary results] Personal communication, Jun. 1, 1987.

49. CHANG, M.-C., FREEDMAN, R., and SUN, T-H. Trends in fertility, family size preferences, and family planning practice: Taiwan, 1961–85. Studies in Family Planning 18(6): 320–337. Nov.-Dec. 1987.

50. CHANTLER, E.N. Copper loss from copper IUDs. In: Zatuchni, G.I., Goldsmith, A., Sciarra, J.J., and Osborn, C.K., eds. Intrauterine contraception: advances and future prospects. Philadelphia, Harper & Row, 1985. p. 198–210.

51. CHEN, P.C. Birth planning. In: United States. Department of Health and Human Services (DHHS). National Institutes of Health. Rural health in the People’s Republic of China: report of a visit by the Rural Health Systems Delegation, Jun. 1978. Washington, D.C., DHHS, 1980. (NIH Pub. No. 81–2124) p. 105–126.

52. CHETWYND, J. and CHAMBERS, H. Contraceptive use and experience amongst a sample of women attending their GP. New Zealand Family Physician 13: 157–160. Spring 1986.

53. CHI, I-C. IUD use in diabetic or lactating women or women after cesarean delivery—an epidemiologic perspective. In: Advances in Contraceptive Delivery Systems (Monograph 2), 1985. p. 287–297.

54. CHI, I-C. and KELLY, E. Is lactation a risk factor of IUD- and sterilization- related uterine perforation? A hypothesis. International Journal of Gynaecology and Obstetrics 22(4): 315–317. Aug. 1984.

55. CHI, I-C., CHAMPION, C.B., and WILKENS, L. Cervical dilation in interval insertion of an IUD: who requires it and does it lead to a high expulsion rate? Contraception 36(4): 403–416. Oct. 1987.

56. CHI, I., FELDBLUM, P.J., and ROGERS, S.M. IUD-related uterine perforation: an epidemiologic analysis of a rare event using an international dataset. Contraceptive Delivery Systems 5: 123–130. 1984.

57. CHI, I-C., GALICH, L.F., TAUBER, P.F., WILKENS, L.R., WASZAK, C.S., SIEMENS, A.J., and LIPPES, J. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception 34(5): 483–495. Nov. 1986.

58. CHI, I-C., GALICH, L.F., TAUBER, P.F., WILKENS, L.R., WASZAK, C.S., SIEMENS, A.J., and LIPPES, J. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception 34(5): 483–495. Nov. 1986.

59. CHI, I-C., JI, G., SIEMENS, A.J., and WASZAK, C.S. IUD insertion at cesarean section—the Chinese experience. Advances in Contraception 2: 145–153. 1986.

60. CHI, I-C., WILKENS, L., and ROGERS, S. Expulsions in immediate postpartum insertions of Lippes Loop D and Copper T IUDs and their counterpart Delta devices—an epidemiological analysis. Contraception 32(2): 119–134. Aug. 1985.

61. CHI, I-C., WILKENS, L.R., and WASZAK, C.S. Difficulty in removal—a neglected IUD-related rare event. In: Advances in Contraceptive Delivery Systems (Monograph 2), 1985. p. 266–274.

62. CHI, I-C., WILKENS, L.R., SIEMENS, A.J., and LIPPES, J. Syncope and other vasovagal reactions at interval insertion of Lippes Loop D—who is most vulnerable? Contraception 33(2): 179–187. Feb. 1986.

63. CHI, I-C., WILKENS, L.R., SIEMENS, A.J., and POTTS, M. Rare events occurring at insertion of an intrauterine device—a review of an international experience. Advances in Contraception 3(1): 49–61. Mar. 1987.

64. CHI, I-C., ZHOU, S.-W., BALOGH, S., and NG, K. Post-cesarean section insertion of intrauterine devices. American Journal of Public Health 74(11): 1281–1282. Nov. 1984.

65. CHILE. MINISTERIO DE SALUD PUBLICO. PROGRAMA DE EXTENSION DE SERVICIOS DE SALUD MATERNO INFANTIL Y BIENESTAR FAMILIAR (PESMIB). Investigaciones en el campo de la salud materno infantil: 25 areas PESMIB 1973–1976: resumen y conclusiones. [Investigations in the field of maternal and child health: 25 areas from the Programa de Extension de Servicios de Salud Materno Infantil y Bienestar Familiar, 1973–1976: summary and conclusions.][SPA] Santiago, Chile, PESMIB, Dec. 1976. p. 3–5, 76–82.

66. CHINA POPULATION INFORMATION CENTRE (CPIC). Analysis on China’s National One-per-thousand-population Fertility Sampling Survey. Beijing, China, CPIC, 1984. 182 p.

67. CHINA. GENERAL OFFICE OF THE STATE FAMILY PLANNING COMMISSION. Statistics on population and family planning of China: 1986. 1987. 8 p. (Unpublished)

68. COHEN, J. Comparaison de DIU au cuivre T 200 avec et sans fil. [A comparative study of the Copper T 200 IUD with and without string.][FRE] Fertilité, Contraception, Sexualité 15(12): 1157–1160. Dec. 1987.

69. COLE, L. (Family Health International) [Event rates for postpartum insertion of various IUDs in multicenter study] Personal communication, Jul. 27, 1987.

70. COLE, L.P. and POTTS, D.M. Wider opportunities for IUD insertion. IPPF Medical Bulletin 17(1): 2–3. Feb. 1983.

71. COLE, L.P., EDELMAN, D.A., POTTS, D.M., WHEELER, R.G., and LAUFE, L.E. Postpartum insertion of modified intrauterine devices. Journal of Reproductive Medicine 29(9): 677–682. Sep. 1984.

72. COLE, L.P., MCCANN, M.F., HIGGINS, J.E., and WASZAK, C.S. Effects of breastfeeding on IUD performance. American Journal of Public Health 73(4): 384–388. Apr. 1983.

73. COLE, L.P., POTTS, D.M., ARANDA, C., BEHLILOVIC, B., ETMAN, S., MORENO, J., and RANDIC, L. An evaluation of the TCu 380Ag and the Multiload Cu375. Fertility and Sterility 43(2): 214–217. Feb. 1985.

74. COLLINS, J.A., GILLETT, P.G., PERLIN, I.A., EMBIL, J.A., ZAYID, I., RICHARDS, G., and KIRK, M.E. Microbiological and histological findings in the fallopian tubes of women using various contraceptive methods. Contraception 30(5): 457–466. Nov. 1984.

75. COLOMBIA. CORPORACIÓN CENTRO REGIONAL DE POBLACIÓN. and INSTITUTE FOR RESOURCE DEVELOPMENT/WESTINGHOUSE (IRD/W). Colombia: Enquesta de Demografia y Salúd 1986, informe preliminar. [Colombia: Demographic and Health Survey 1986, preliminary report.] [SPA] Columbia, Maryland, IRD/W, 1987. 34 p.

76. CONSUMERS UNION. The manufactured crisis: liability-insurance companies have created a crisis and dumped it on you. Consumer Reports, Aug. 1986. p. 544–549.

77. COSTA RICA DEMOGRAPHIC ASSOCIATION (CRDA). and UNITED STATES. CENTERS FOR DISEASE CONTROL (CDC). The Costa Rica Fertility and Health Survey, 1986. [San Jose,] Costa Rica and Atlanta, Georgia, CRDA and CDC, Sep. 1987. 100 p.

* 78. CRAMER, D.W., SCHIFF, I., SCHOENBAUM, S.C., GIBSON, M., BELISLE, S., ALBRECHT, B., STILLMAN, R.J., BERGER, M.J., WILSON, E., STADEL, B.V., and SEIBEL, M. Tubal infertility and the intrauterine device. New England Journal of Medicine 312(15): 941–947. Apr. 11, 1985.

79. CRUESEN, L. (Organon International) [Development of MLCu-375 SL) Personal communication, Dec. 11, 1987.

80. CRUESEN, L. (Organon International) [Multiload production in Brazil] Personal communication, Jan. 15, 1988.

* 81. DALING, J.R., WEISS, N.S., METCH, B.J., CHOW, W.H., SODERSTROM, R.M., MOORE, D.E., SPADONI, L.R., and STADEL, B.V. Primary tubal infertility in relation to the use of an intrauterine device. New England Journal of Medicine 312(15): 937–941. Apr. 11, 1985.

* 82. DELANO, G.E. Intrauterine contraceptive device: clinical manual. [Boston], Pathfinder Fund, [1987]. 26 p.

83. DELGADO, G. (APROFA) [IUD use in Chile] Personal communication, Jul. 17, 1987.

84. DÍAZ, S., PAVEZ, M., CÁRDENAS, H., and CROXATTO, H.B. Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs. Contraception 35(6): 569–579. Jun. 1987.

85. DIEBEN, T. (Organon International) [Research on MLCu-250 with antiseptic coated strings] Personal communication, Dec. 17, 1987.

86. DOMINICAN REPUBLIC. CONSEJO NACIONAL DE POBLACIÓN Y FAMILIA (CONAPOFA). and INSTITUTE FOR RESOURCE DEVELOPMENT/ WESTINGHOUSE (IRD/W). Encuesta demografica y de salud 1986. [Demographic and health survey 1986.][SPA] Santa Domingo, Dominican Republic, NCPF, and [Columbia, Maryland], IRD/W, Feb. 1987. 21 p.

87. DORING, G., BAUR, S., FRANK, P., FREUNDL, G., and SOTTONG, U. Ergebnisse einer repräsentativen Umfrage zum Familienplanungsverhalten in der Bundesrepublik Deutschland 1985. [Results of a representative survey of family planning behavior in the Federal Republic of Germany 1985.][GER] Geburtshilfe und Frauenheilkunde 12(46): 857–920. Dec. 1986.

88. DREHER, E., CIMBER, H., and MUHLEMANN, M. Intrauterine occlusion body (IUB): preliminary report. [1987]. 18 p. (Unpublished)

89. DROST, R.H., MAES, R., and THIERY, M. Copper release from the MLCu375 intrauterine contraceptive device. IRCS Journal of Medical Science 11(10): 895. Oct. 1983.

90. EDELMAN, D.A., BERGER, G.S., and KEITH, L.G. Intrauterine devices and their complications. Boston, G.K. Hall, 1979. 263 p.

91. EDELMAN, D.A., ZIPPER, J., RIVERA, M., and MEDEL, M. Timing of the IUD insertion. Contraception 19(5): 449–454. May 1979.

92. ELSTEIN, M. Pelvic inflammation and the intrauterine contraceptive device. Proceedings of the Royal Society of Medicine 60(4): 397. Apr. 1967.

93. ESCHENBACH, D.A. Acute pelvic inflammatory disease. Urologic Clinics of North America 11(1): 65–81. Feb. 1984.

94. ESCHENBACH, D.A. Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstetrics and Gynecology 55(5, Suppl.): 142S-152S. May 1980.

95. ESCHENBACH, D.A. and SODERSTROM, R.M. IUDs and salpingitis. In: Hafez, E.S.E. and Van Os, W.A.A., eds. IUD pathology and management. Boston, G.K. Hall, 1980. (Progress in Contraceptive Delivery Systems Vol. 3) p. 147–158.

96. FAMILY HEALTH INTERNATIONAL. Careful IUD insertion can reduce STD transmission. Network 8(2): 7. Winter 1987.

97. FAMILY HEALTH INTERNATIONAL. IUDs and PID: understanding the American situation. Network 8(2): 8. Winter 1987.

98. FAMILY HEALTH INTERNATIONAL. IUD Update: What family planners should know. 8(2): 1-3. Winter 1987.

99. FAMILY HEALTH INTERNATIONAL. Postpartum IUDs in Mexico. Network 6(2): 8. Winter 1985.

100. FAMILY HEALTH INTERNATIONAL. Preventing PID in IUD acceptors at insertion. Network 8(2): 3. Winter 1987.

101. FAMILY PLANNING ASSOCIATION OF HONG KONG (FPAHK). Family planning knowledge, attitude and practice in Hong Kong 1982. Wanchai, Hong Kong, FPAHK, 1984. 125 p.

102. FARLEY, T.M.M. Life-table methods for contraceptive research. Statistics in Medicine 5: 475–489. 1986.

103. FAULKNER, W.L. and ORY, H.W. Intrauterine devices and acute pelvic inflammatory disease. Journal of the American Medical Association 235(17): 1851–1853. Apr. 26, 1976.

104. FINISHING ENTERPRISES (FI). Prescribing information: Copper T model TCu 200B. North Tonawanda, New York, FI, 1985. 6 p. (Pamphlet)

105. FINISHING ENTERPRISES (FI). Prescribing information: Copper T model TCu 380A. North Tonawanda, New York, FI, 1985. 6 p. (Pamphlet)

106. FISHEL, S.B. and EDWARDS, R.G. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 223 (4638): 816–818. Feb. 24, 1984.

* 107. FISHER, A.A. and SILVA, V. DE. Satisfied IUD acceptors as family planning motivators in Sri Lanka. Studies in Family Planning 17(5): 235–242. Sep.-Oct. 1986.

108. FLESH, G., WEINER, J.M., CORLETT, R.C., Jr., BOICE, C., MISHELL, D.R., Jr., and WOLF, R.M. The intrauterine contraceptive device and acute salpingitis: a multifactor analysis. American Journal of Obstetrics and Gynecology 135(3): 402–408. Oct. 1, 1979.

109. FOREMAN, H., STADEL, B.V., and SCHLESSELMAN, S. Intrauterine device usage and fetal loss. Obstetrics and Gynecology 58(6): 669–677. Dec. 1981.

110. FORNARY, J. (International Planned Parenthood Federation (IPPF)) [IPPF IUD supplies 1986–87] Personal communication, Oct. 23, 1987.

111. FORREST, J.D. The end of IUD marketing in the United States: What does it mean for American women? Family Planning Perspectives 18(2): 52–57. Mar.-Apr. 1986.

112. FRASER, S. Vietnam’s campaign makes progress. People 14(3): 25. 1987.

* 113. GALLEN, M. and LETTENMAIER, C.L. Counseling makes a difference. Population Reports, Series J, No. 35. Baltimore, Johns Hopkins University, Population Information Program, Jul.-Aug. 1987. 32 p.

114. GALVEZ, R.S., GALICH, L., GUIROLA, A.M., COLE, L.P., and WASZAK, C. A comparative study of the TCu200B with and without strings. Advances in Contraceptive Delivery Systems 1: 107–112. 1985.

115. GAO J., ZENG S., SUN B., WU S., DONG J., CONG J., ZHU X., FAN H., HAN L., and ZHENG X. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs. Contraception 34(6): 559–571. Dec. 1986.

116. GIBOR, Y. and PHARRIS, B. Grossesse extra-uterine et D.I.U. [Extrauterine pregnancies and IUD use.][FRE] Contraception, Fertilite, Sexualite 8(2): 109–120. Feb. 1980.

117. GOH, T.H. and HARIHARAN, M. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels. Contraception 28(4): 329–336. Oct. 1983.

118. GOH, T.H. and TONG, S.L. Patterns of copper loss—a comparison of the multiload Cu250, TCu-220C and Cu7 IUDs. Contraception 33(4): 411–420. Apr. 1986.

119. GOH, T.H., ANG, E.S., and YIP, Y.C. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion. Journal of Obstetrics and Gynaecology 4(2): 127–128. Oct. 1983.

120. GOH, T.H., HARIHARAN, M., and CHAN, G.L. Anaemia and menstrual blood loss studies in women using Multiload Cu250 and Progestasert IUDs. Contraception 29(4): 359–366. Apr. 1984.

121. GOH, T.H., HUTAPEA, H., MCCARTHY, T., et. al. A multicenter randomized comparative investigation of ML Cu250, TCu-220C and Cu7 IUDs. Advances in Contraceptive Delivery Systems, 1985. (Monograph 1) p. 126–130.

122. GOLDMAN, N., PEBLEY, A.R., and WESTOFF, C.F. Probabilities of conception in Latin America. Presented at the annual meeting of the Population Association of America, Apr. 30, 1982. 30 p.

123. GOLDSTUCK, N.D. Pain reduction during and after insertion of an intrauterine contraceptive device. Advances in Contraception 3(1): 25–36. Mar. 1987.

124. GONZALEZ, M.L., EMMONS, D.W., and PIENIAZEK, D. Socioeconomic characteristics of medical practice 1986. Chicago, Illinois, American Medical Association, 1986. p. 12–16, 136–137.

125. GRAY, R.H. and LABBOK, M. Family planning components in community based distribution projects: risk/benefit considerations in the choice of methods. In: Wawer, M., Huffman, S., Cebula, D., and Osborn, R. Health and family planning in community-based distribution programs. Boulder, Colorado, Westview Press, 1985. p. 65–103.

* 126. GRAY, R.H., RAMOS, R., AKIN, A., and BERNARD, R. Manual for the provision of intrauterine devices (IUDs). Geneva, World Health Organization, 1980. 51 p.

* 127. GRIMES, D.A. Intrauterine devices and pelvic inflammatory disease: recent developments. Contraception 36(1): 97–110. Jul. 1987.

128. GRIMES, D.A. Nongonococcal pelvic inflammatory disease. Clinical Obstetrics and Gynecology 24(4): 1227–1243. Dec. 1981.

129. GUERRA, F., WARREN, C.W., OBERLE, M.W., and MORRIS, L. Maternal-child health/family planning survey: Panama 1984. Atlanta, Georgia, Centers for Disease Control, Mar. 1986. 140 p.

130. GUILLEBAUD, J. Scheme for management of "lost" IUD threads. IPPF Medical Bulletin 14(5): 1–3. Oct. 1980.

131. GUILLEBAUD, J. and BONNAR, J. Estimation and prediction of IUD-related increased duration and amount of menstrual blood loss. In: Hafez, E.S.E. and Van Os, W.A.A., eds. IUD pathology and management. Boston, G.K. Hall, 1980. (Progress in Contraceptive Delivery Systems Vol. 3) p. 75–92.

132. GUILLEBAUD, J. and BONNAR, J. Longer though lighter menstrual and intermenstrual bleeding with copper as compared to inert intrauterine devices. British Journal of Obstetrics and Gynaecology 85(9): 707–712. Sep. 1978.

133. GUILLEBAUD, J. and KASONDE, J.M. A simple scheme for managing the problem of "lost threads" with intrauterine devices. Fertility and Contraception 3(2): 24–32. Apr. 1979.

134. GUILLEBAUD, J., BARNETT, M.D., and GORDON, Y.B. Plasma ferritin levels as an index of iron deficiency in women using intrauterine devices. British Journal of Obstetrics and Gynaecology 86(1): 51–55. Jan. 1979.

135. GUILLEBAUD, J., BONNAR, J., MOREHEAD, J., and MATHEWS, A. Menstrual blood-loss with intrauterine devices. Lancet 1(7956): 387–390. Feb. 21, 1976.

136. GUMP, D.W., GIBSON, M., and ASHIKAGA, T. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women. American Journal of Obstetrics and Gynecology 146(2): 153–159. May 15, 1983.

137. GUTTMACHER, A.F. Intrauterine contraceptive devices. Journal of Reproduction and Fertility 10: 115–128. 1965.

138. HAGER, W.D., ESCHENBACH, D.A., SPENCE, M.R., and SWEET, R.L. Criteria for diagnosis and grading of salpingitis. Obstetrics and Gynecology 61(1): 113–114. Jan. 1983.

139. HALL, J.M. and BLEICH, J. Manufacturer halts Saf-T-Coil production. Contraceptive Technology Update 3(9): 109–110. Sep. 1982.

140. HARLAP, S. HIV and fertility regulation. 1987. 25 p. (Unpublished)

141. HASSON, H.M., BERGER, G.S., and EDELMAN, D.A. Factors affecting intrauterine contraceptive device performance: 1. Endometrial cavity length. American Journal of Obstetrics and Gynecology 126(8): 973–981. Dec. 15, 1976.

142. HATCHER, R.A., GUEST, F., STEWART, F., STEWART, G.K., TRUSSELL, J., CEREL, S., and CATES, W. Contraceptive technology 1986–1987. 13th rev. ed. New York, Irvington Publishers, 1986. 310 p.

143. HAUB, C. and KENT, M.M. 1987 world population data sheet. [Wall chart] Washington, D.C., Population Reference Bureau, 1987.

144. HEARTWELL, S.F. and SCHLESSELMAN, S. Risk of uterine perforation among users of intrauterine devices. Obstetrics and Gynecology 61(1): 31–36. Jan. 1983.

145. HEATH, K., MARTINEZ, D., and SHEON, A.R. Trinidad and Tobago Demographic and Health Survey (TTDHS) 1987: preliminary report. [Port-of-Spain], Trinidad and Tobago. [and Columbia, Maryland], Family Planning Association of Trinidad and Tobago. and Institute for Resource Development/Westinghouse, Jan. 1988. 22 p.

146. HEIKKILÄ, M., HAUKKAMAA, M., and LUUKKAINEN, T. Contraception with a levonorgestrel-releasing IUD: effect on lactation and child development. In: Zatuchni, G.I., Goldsmith, A., Shelton, J.D., Sciarra, J.J., and Osborn, C.K., eds. Long-acting contraceptive delivery systems. Philadelphia, Harper & Row, 1984. p. 368–377.

147. HEIKKILÄ, M., NYLANDER, P., and LUUKKAINEN, T. Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device. Contraception 26(5): 465–474. Nov. 1982.

148. HERMANNS, U. and HAFEZ, E.S.E. IUD use and carcinoma of the cervix. Contraceptive Delivery Systems 2(1): 109–119. Apr. 1981.

149. HEROLD, J.M., WARREN, C.W., SMITH, J.C., ROCHAT, R.W., MARTINEZ, R., and VERA, M. Contraceptive use and the need for family planning in Puerto Rico. International Family Planning Perspectives 12(4): 125–131. Dec. 1986.

150. HIRVONEN, E., KAIVOLA, S., and TIMONEN, H. Fincoid—a new copper IUD: a preliminary report. Contraceptive Delivery Systems 3(2): 83–89. Apr. 1982.

151. HONDURAS. MINISTRY OF PUBLIC HEALTH (HMPH). and ASSOCIATION FOR FAMILY PLANNING IN HONDURAS (ASHONPLAFA). Maternal-child health and family planning survey: Honduras, 1984: Final report. [Tegucigalpa, Honduras], HMPH and ASHONPLAFA, Dec. 1986. 202 p.

152. HONORE, L.H. The intrauterine contraceptive device and hydatidiform mole: a negative association. Contraception 34(2): 213–219. Aug. 1986.

153. HÖPFLINGER, F. and KÜHNE, F. Contraception: answers of wives and husbands compared in a survey of Swiss couples. Journal of Biosocial Science 16(2): 259–268. Apr. 1984.

154. HSU, C.-T., ROAN, C.-H., CHANG, H.-T., CHEN, S.-Z., LIN, Y.-N., and CHEN, T.-Y. Uterine malignancies developing after a long term use of IUCD’s. Asia-Oceania Journal of Obstetrics and Gynaecology 10(3): 347–357. Sep. 1984.

155. HUNGARY. CENTRAL STATISTICAL OFFICE (CSO). Summary of the 1986 fertility surveys. Budapest, CSO, 1987. 21 p.

* 156. HUTCHINGS, J.E., BENSON, P.J., PERKIN, G.W., and SODERSTROM, R.M. The IUD after 20 years: a review of worldwide experience. International Family Planning Perspectives 11(3): 77–86. Sep. 1985.

157. INDONESIA. BUREAU OF PUBLIC STATISTICS (BPS). Ulasan singkat: hasil Survei Penduduk Antar Sensus 1985. [A brief note on the results of the 1985 Intercensal Population Survey.] Jakarta, BPS, 1985. (Series No. 4)

158. INSTITUTE OF POPULATION STUDIES. Preliminary assessment of the Fincoid IUD. Devon, England, University of Exeter, 1980. (Report 3/80) 30 p.

159. INTERNATIONAL FEDERATION OF FERTILITY SOCIETIES. The Singapore statement on IUDs. Oct. 30, 1986. 1 p. (Unpublished)

160. INTERNATIONAL FERTILITY RESEARCH PROGRAM. Intrauterine device study: clinical table 4: events after insertion. [Table] [1982]. 1 p. (Unpublished)

* 161. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). Concerns in the USA about IUDs—IMAP’s comments. IPPF Medical Bulletin 20(2): 1. Apr. 1986.

162. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). Contraceptive and medical services. [Policy compendium] [London], IPPF, Nov. 1985. 5 p.

163. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). Family planning in Chile: a profile of the development of policies and programmes. London, IPPF, [1980]. 25 p.

* 164. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). IPPF International Medical Advisory Panel meetings, 1987. IPPF Medical Bulletin 21(6): 3–6. Dec. 1987.

165. INTERNATIONAL PLANNED PARENTHOOD FEDERATION. Guidelines for IUD sterilization. IPPF Medical Bulletin 19(6): 3. Dec. 1985.

166. IOFFREDA, I. (International Development Procurement Services) [Shipment of IUDs for International Planned Parenthood, 1983–85] Personal communication, Nov. 10, 1987.

167. ISRAEL, R., SHAW, S.T., Jr., and MARTIN, M.A. Comparative quantitation of menstrual blood loss with the Lippes Loop, Dalkon Shield, and Copper T intrauterine devices. Contraception 10(1): 63–71. Jul. 1974.

168. JACOB, M., SHAHMANESH, M., WHATLEY, J., and THIN, N. A forgotten factor in pelvic inflammatory disease: infection in the male partner. British Medical Journal 294(6576): 869. Apr. 4, 1987.

169. JACOBSON, L. and WESTROM, L. Objectivized diagnosis of acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 105: 1088–1098. Sep.-Dec. 1969.

170. JAGDEO, T.P. Contraceptive prevalence in Grenada. New York, International Planned Parenthood Federation, Western Hemisphere Region, 1987. (IPPF/WHR Caribbean Contraceptive Prevalence Surveys No. 3) 169 p.

171. JAGDEO, T.P. Contraceptive prevalence in Montserrat. New York, International Planned Parenthood Federation, Western Hemisphere Region, 1985. (IPPF/WHR Caribbean Contraceptive Prevalence Surveys No. 2) 152 p.

172. JAGDEO, T.P. Contraceptive prevalence in St. Kitts-Nevis. New York, International Planned Parenthood Federation, Western Hemisphere Region, 1985. 126 p.

173. JAIN, A.K. Comparative performance of three types of IUDs in the United States. In: Hefnawi, F. and Segal, S.J., eds. Proceedings of the Third International Conference on Intrauterine Contraception, Cairo, Egypt, Dec. 12–14, 1974. Amsterdam, North-Holland, 1975. p. 3–16.

* 174. JOHANNISSON, E. Mechanism of action of intrauterine devices: biochemical changes. Contraception 36(1): 11–22. Jul. 1987.

175. KAMNUANSILPA, P. and CHAMRATRITHIRONG, A. Contraceptive use and fertility in Thailand: results from the 1984 Contraceptive Prevalence Survey. Bangkok, National Institute of Development Administration, Research Center; Mahidol University, Institute for Population and Social Research; and Ministry of Public Health, National Family Planning Program, 1985. 154 p.

176. KAUFMAN, D.W., SHAPIRO, S., ROSENBERG, L., MONSON, R.R., MIETTINEN, O.S., STOLLEY, P.D., and SLONE, D. Intrauterine contraceptive device use and pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 136(2): 159–162. Jan. 15, 1980.

177. KAUFMAN, D.W., WATSON, J., ROSENBERG, L., HELMRICH, S.P., MILLER, D.R., MIETTINEN, O.S., STOLLEY, P.D., and SHAPIRO, S. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease. Journal of the American Medical Association 250(6): 759–762. Aug. 12, 1983.

178. KAUNITZ, A.M. and GRIMES, D.A. Good news about contraceptives and PID. Contemporary Ob/Gyn 27(3): 153–157. Mar. 1986.

179. KAYE, B.M., REANEY, B.V., KAYE, D.L., and EDELMAN, D.A. Long-term safety and use-effectiveness of intrauterine devices. Fertility and Sterility 28(9): 937–942. Sep. 1977.

180. KENYA. CENTRAL BUREAU OF STATISTICS (CBS). Kenya Contraceptive Prevalence Survey 1984: first report. Nairobi, CBS, Dec. 1984. 160 p.

181. KETTING, E. and LELIVELD, F. Abortus en anticonceptie anno 1982: Jaarverslag van de Permanente Registratie Abortus, aangevuld met diverse onderzoeksgegevens betreffende anticonceptiegebruik in Nederland. [Abortion and contraception in 1982. Annual report from the Permanent Registration of Abortion, supplemented by various research data relating to the use of contraceptives in the Netherlands.][DUT, summary in ENG] The Hague, Netherlands, Vereniging Stimezo Nederland, 1983. 182 p.

182. KETTING, E. and VAN OS, W.A.A. IUD use in western Europe. In: Zatuchni, G.I., Goldsmith, A., and Sciarra, J.J. Intrauterine contraception: advances and future prospects. Philadelphia, Harper & Row, 1985. p. 37–44.

183. KEY, T.C. and KREUTNER, A.K. Gastrointestinal complications of modern intrauterine devices. Obstetrics and Gynecology 55(2): 239–244. Feb. 1980.

184. KHAN, M., RAHMAN, S., JAHA, N.K., and HUQ, N. A prospective study of IUD in Dhaka city. In: Khan, A.R. and Mia, A., eds. Contraceptive practice in Bangladesh: safety issues. Dhaka, Bangladesh, Program for the Introduction and Adaptation of Contraceptive Technology/Program for Appropriate Technology in Health, Nov. 1984. p. 304–335.

185. KHAN, M.E. and PRASAD, C.V.S. Family planning practices in India— Second All India Survey. Baroda, India, Operations Research Group, 1983. 215 p.

186. KIM-FARLEY, R.J., CATES, W., Jr., ORY, H.W., and HATCHER, R.A. Febrile spontaneous abortion and the IUD. Contraception 18(6): 561–570. Dec. 1978.

187. KIRKWOOD, B.J., FACER, W.A.P., LAWRENCE, G.M., and HUNTON, R.B. Contraceptive practice among New Zealand women. New Zealand Medical Journal 89(641): 108–111. Aug. 8, 1979.

188. KIVIJÄRVI, A., TIMONEN, H., RAJAMÄKI, A., and GRÖNROOS, M. Iron deficiency in women using modern copper intrauterine devices. Obstetrics and Gynecology 67(1): 95–98. Jan. 1986.

189. KLEIN-ECHEVERRI, L. (Pathfinder Fund) [Pathfinder Fund IUD supplies, 1980–87] Personal communication, May 27, 1987.

190. KLEINMAN, R.L., ed. Family planning handbook for doctors. 5th ed. London, International Planned Parenthood Federation, 1980. 243 p.

* 191. KLEINMAN, R.L., ed. Family planning handbook for midwives and nurses. 3rd ed. London, International Planned Parenthood Federation, 1986. 79 p.

192. KOBAYASHI, K. Contraception. In: Mainichi Newspapers Population Problems Research Council (MNPPRC). Summary of eighteenth national survey on family planning. Tokyo, MNPPRC, 1986. p. 97–109.

193. KOCH, J.U. Sperm migration in the human female genital tract with and without intrauterine devices. Acta Europaea Fertilitatis 11(1): 33–60. Mar. 1980.

194. KOCH, U.J. Cytological investigations in women with the IUD ML Cu 250 in situ and other methods of fertility regulation. Presented at the Reproductive Health Care International Symposium, Maui, Hawaii, Oct. 10–15, 1982. 9 p.

195. KOETSAWANG, S., RACHAWAT, D., and PIYA-ANANT, M. Outcome of pregnancy in the presence of intrauterine device. Acta Obstetricia et Gynecologica Scandinavica 56(5): 479–482. 1977.

196. KOLS, A., RINEHART, W., PIOTROW, P.T., DOUCETTE, L., and QUILLIN, W.F. Oral contraceptives in the 1980s. Population Reports, Series A, No. 6. Baltimore, Johns Hopkins University, Population Information Program, May-Jun. 1982. 36 p.

197. KOREA INSTITUTE FOR POPULATION AND HEALTH (KIPH). [1985 fertility and family health survey].[KOR] Seoul, Korea, KIPH, 1985. 390 p.

198. KOSASA, T., LEVESQUE, L., GOLDSTEIN, D.P., and TAYMOR, M.L. Early detection of implantation using a radioimmunoassay specific for human chorionic gonadotropin. Journal of Clinical Endocrinology and Metabolism 36(3): 622–624. 1973.

199. KOSONEN, A. Corrosion of copper in utero. Fertility and Sterility 30(1): 59–65. Jul. 1978.

200. KO•UH, M., ANDOLSEK, L., and ALLONEN, H. A randomized comparative trial of Nova-T and TCu200Ag in Yugoslavia. Advances in Contraception 2(1): 31–36. Mar. 1986.

201. KO•UH-NOVAK, M., ANDOLŠEK, L., HREN-VENCELJ, H., GUBINA, M., and KRALJ, B. Risk factors for pelvic inflammatory disease in IUD users. In: Hasson, H., Hafez, E.S.E., and Van Os, W.A.A., eds. Biomedical aspects of IUDs. Hingham, Massachusetts, MTP Press, 1985. (Advances in Reproductive Health Care) p. 65–76.

202. KUBBA, A.A. and BOUNDS, W. (Margaret Pyke Centre) [Retrieval of missing IUD strings] Personal communication, Oct. 10, 1987.

203. LADIPO, O.A. Training of midwives in family planning in Nigeria. Planners’ Forum 1(1): 5–6. 1983.

204. LAING, J.E. Continuation and effectiveness of contraceptive practice: a cross-sectional approach. Studies in Family Planning 16(3): 138–153. May-Jun. 1985.

205. LARSON, A. Fertility and the status of women. [Wall chart] Washington, D.C., Population Reference Bureau, [1981].

206. LARSSON, B., FRANKMAN, O., and HAMBERGER, L. Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device). Fertility and Sterility 36(6): 734–736. Dec. 1981.

207. LARSSON, B., HAMBERGER, L., and RYBO, G. Influence of copper intrauterine contraceptive devices (Cu-7-IUD) on the menstrual blood-loss. Acta Obstetricia et Gynecologica Scandinavica 54(4): 315–318. 1975.

* 208. LEE, N.C., RUBIN, G.L., and BORUCKI, R. The intrauterine device and pelvic inflammatory disease: new results from the Women’s Health Study. (To be published by Obstetrics and Gynecology)

* 209. LEE, N.C., RUBIN, G.L., ORY, H.W., and BURKMAN, R.T. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstetrics and Gynecology 62(1): 1–6. Jul. 1983.

210. LEHFELDT, H. Comparative study of two intra-uterine contraceptive devices. [Abstract] In: Segal, S.J., Southam, A.L., and Shafer, K.D., eds. Intra- uterine contraception. Amsterdam, Excerpta Medica, 1965. (International Congress Series No. 86) p. 237.

211. LEHFELDT, H. Immediate postabortion insertion of an IUD. European Journal of Obstetrics, Gynecology and Reproductive Biology 17(2–3): 141–147. May 1984.

212. LEIDHOLM, P., RYBO, G., SJOBERG, N.-O., and SOLVELL, L. Copper IUD: influence on menstrual blood loss and iron deficiency. Contraception 12(3): 317–325. Sep. 1975.

213. LEISHMAN, G. (Ortho Pharmaceuticals, Canada) [Instructions for copper IUD use] Personal communication, Oct. 13, 1987.

* 214. LETTENMAIER, C.L. and GALLEN, M. Counseling guide. Population Reports, Series J, No. 36. Baltimore, Johns Hopkins University, Population Information Program, Sep.-Oct. 1987. 28 p.

215. LEWIT, S. Outcome of pregnancy with intrauterine devices. Contraception 2(1): 47–57. Jul. 1970.

216. LIPPES, J. A study of intra-uterine contraception: development of a plastic loop. In: Tietze, C. and Lewit, S., eds. Intra-uterine contraceptive devices. (Proceedings of the conference, New York, Apr. 30-May 1, 1962) Amsterdam, Excerpta Medica, 1962. p. 383–390.

217. LISKIN, L., BLACKBURN, R., and GHANI, R. Hormonal contraception: new long-acting methods. Population Reports, Series K, No. 3. Baltimore, Johns Hopkins University, Population Information Program, Mar.-Apr. 1987. 32 p.

218. LISKIN, L., BLACKBURN, R., and MAIER, J.H. AIDS—a public health crisis. Population Reports, Series L, No. 6. Baltimore, Johns Hopkins University, Population Information Program, Jul.-Aug. 1986. 36 p.

219. LISKIN L. and FOX, G. IUDs: an appropriate contraceptive for many women. Population Reports, Series B, No. 4. Baltimore, Johns Hopkins University, Population Information Program, July 1982. 36 p.

* 220. LONDON, K., CUSHING, J., CLELAND, J., ANDERSON, J.E., MORRIS, L., MOORE, S.H., and RUTSTEIN, S.O. Fertility and family planning surveys: an update. Population Reports, Series M, No. 8. Baltimore, Johns Hopkins University, Population Information Program, Sep.-Oct. 1985. 60 p.

221. LUDI, J. (FUNDATECH S.A.) [Fundus-fixing IUD] Personal communication, Aug. 21, 1987.

222. LUUKKAINEN, T. and NILSSON, C.G. Sustained intrauterine release of d-norgestrel. Contraception 18(4): 451–458. Oct. 1978.

223. LUUKKAINEN, T. and NILSSON, C.G. The development of levonorgestrel IUD. [1982]. 29 p. (Unpublished)

224. LUUKKAINEN, T., ALLONEN, H., HAUKKAMAA, M., et. al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception 36(2): 161–179. August 1987.

* 225. LUUKKAINEN, T., ALLONEN, H., HAUKKAMAA, M., LÄHTEENMÄKI, P., NILSSON, C.G., and TOIVONEN, J. Five years’ experience with levonorgestrel-releasing IUDs. Contraception 33(2): 139–148. Feb. 1986.

226. LUUKKAINEN, T., ALLONEN, H., NIELSEN, N.-C., NYGREN, K.-G., and PYÖRÄLÄ, T. Five years’ experience of intrauterine contraception with the Nova-T and the Copper-T-200. American Journal of Obstetrics and Gynecology 147(8): 885–892. Dec. 15, 1983.

227. LUUKKAINEN, T., NIELSEN, N.-C., NYGREN, K.-G., and PYÖRÄLÄ, T. Nulliparous women, IUD and pelvic infection. Annals of Clinical Research 11(4): 121–124. 1979.

228. MACFARLAN, S.M. Perforation of the postpartum uterus with an intrauterine contraceptive device. American Journal of Obstetrics and Gynecology 94(2): 283. Jan. 15, 1966.

229. MALMQVIST, R., PETERSOHN, L., and BENGTSSON, L.P. Menstrual bleeding with copper-covered intrauterine contraceptive devices. Contraception 9(6): 627–633. Jun. 1974.

230. MAURITIUS. MINISTRY OF HEALTH (MOH). FAMILY PLANNING/ MATERNAL-CHILD HEALTH DIVISION. Mauritius Contraceptive Prevalence Survey 1985: final report. Port Louis, Mauritius, MOH, Feb. 1987. 134 p.

231. MILLS, A. and BIDDELL, S. AIDS (acquired immune deficiency syndrome), family planning and well woman services. British Journal of Family Planning 13(1): 11–15. Apr. 1987.

232. MISHELL, D.R., Jr. Pregnancy-related complications and bleeding problems with IUDs. In: Sciarra, J.J., Zatuchni, G.I., and Speidel, J.J., eds. Risks, benefits and controversies in fertility control. Hagerstown, Maryland, Harper & Row, 1978. p. 428–434.

233. MISHELL, D.R., Jr. and ROY, S. Copper intrauterine contraceptive device event rates following insertion 4 to 8 weeks post partum. American Journal of Obstetrics and Gynecology 143(1): 29–35. May 1, 1982.

234. MISHELL, D.R., Jr., BELL, J.H., GOOD, R.G., and MOYER, D.L. The intrauterine device: a bacteriologic study of the endometrial cavity. American Journal of Obstetrics and Gynecology 96(1): 119–126. Sep. 1, 1966.

235. MISHELL, D.R., Jr., ISRAEL, R., and FREID, N. A study of the Copper T intrauterine contraceptive device (TCu 200) in nulliparous women. American Journal of Obstetrics and Gynecology 116(8): 1092–1096. Aug. 15, 1978.

236. MITRA AND ASSOCIATES (MA). Bangladesh Contraceptive Prevalence Survey-1985: key tables. Dhaka, MA, 1985. 24 p.

237. MITTAL, S., GUPTA, I., LATA, P., MAHAJAN, U., and GUPTA, A.N. Management of translocated and incarcerated intrauterine contraceptive devices. Australian and New Zealand Journal of Obstetrics and Gynaecology 26: 232–234. 1986.

238. MIZNE, S. (Produtos Medicos Ltd.) [IUD production in Brazil] Personal communication, Aug. 11, 1987.

239. MOROCCO. MINISTERE DE LA SANTE PUBLIQUE. SERVICE D’ETUDE DE INFORMATION SANITAIRE. and INSTITUTE FOR RESOURCE DEVELOPMENT/WESTINGHOUSE (IRD/W). Enquête nationale sur la planification familiale, la fecondite et la sante de la population au Maroc (ENDS), 1987. [National study on family planning, fertility and health of the Moroccan population (ENDS), 1987.][SPA] Columbia, Maryland, IRD/W, Oct. 1987. 20 p.

240. MORROW, P. (Program for the Introduction and Adaptation of Contraceptive Technology) [IUD research and manufacturing in China] Personal communication, Oct. 29, 1987.

241. MOSHER, W.D. Contraceptive utilization, United States, 1976. Data from the National Survey of Family Growth. Vital and Health Statistics, Series 23, No. 7, Mar. 1981. 58 p.

242. MOSHER, W.D. and BACHRACH, C.A. Contraceptive use: United States, 1982. Hyattsville, Maryland, US Department of Health and Human Services, National Center for Health Statistics, Sep. 1986. (Vital and Health Statistics Series 23, No. 12) 52 p.

243. MOYER, D.L. and MISHELL, D.R., Jr. Reactions of human endometrium to the intrauterine foreign body: 2. Long-term effects on the endometrial histology and cytology. American Journal of Obstetrics and Gynecology 111: 68–80. Sep. 1, 1971.

244. MUIR, D.G. and BELSEY, M.A. Pelvic inflammatory disease and its consequences in the developing world. American Journal of Obstetrics and Gynecology 138(7, Pt.2): 913–928. Dec. 1, 1980.

245. MÜNZ, R. Leben mit Kindern: Wunsch und Wirklichkeit. [Living with children: desire and reality.][GER] Vienna, Franz Deuticke Verlagsgesellschaft, 1985. 385 p.

246. MURPHY, T. Ortho stops marketing Lippes Loop; cites economic factors. Contraceptive Technology Update 6(11): 149–152. Nov. 1985.

247. MURRAY, S., HICKEY, J.B., and HOUANG, E. Significant bacteremia associated with replacement of intrauterine contraceptive device. American Journal of Obstetrics and Gynecology 156(3): 698–700. Mar. 1987.

248. N’DIAYE, S., SARR, I., and AYAD, M. Enquête demographique et de sante au Senegal 1986: rapport preliminaire. [Senegal Demographic and Health Survey 1986: preliminary results.][FRE] Columbia, Maryland, Institute for Resource Development/Westinghouse, 1986. 39 p.

249. NASH, H. (Population Council) [Planned research for the levonorgestrel-releasing IUD and TCu-380Ag; lifespan of copper IUDs] Personal communication, Oct. 2, 1987.

250. NEHRA, P.C. and MAGYAR, D.M. Hematologic characteristics in IUD users. Contraceptive Delivery Systems 3(2): 149–154. Apr. 1982.

251. NEPAL. MINISTRY OF HEALTH (MOH). PLANNING, RESEARCH AND EVALUATION DIVISION. NEPAL FAMILY PLANNING AND MATERNAL CHILD HEALTH PROJECT. Preliminary report: findings from Nepal fertility and family planning survey, 1986. Kathmandu, Nepal, MOH, Jul. 1986. 51 p. (Mimeo)

252. NEWTON, J.R. Copper intrauterine devices: evaluation for long-term use: a review. British Journal of Obstetrics and Gynaecology (Suppl. 4): 20–31. Sep. 1982.

253. NEWTON, W. and KEITH, L.G. Role of sexual behavior in the development of pelvic inflammatory disease. Journal of Reproductive Medicine 30(2): 82–88. Feb. 1985.

254. NIELSEN, N.-C., PYÖRÄLÄ, T., ALLONEN, H., NYGREN, K.-G., and LUUKKAINEN, T. Four years of the comparative study with Nova T and Copper T 200. [1982]. 22 p. (Unpublished)

255. NIGERIA. ONDO STATE. MINISTRY OF HEALTH. MEDICAL/PREVENTATIVE HEALTH DIVISION. and INSTITUTE FOR RESOURCE DEVELOPMENT/WESTINGHOUSE (IRD/W). Ondo State, Nigeria: Demographic and Health Survey 1986: preliminary report. Columbia, Maryland, IRD/W, Aug. 1987. 20 p.

256. NIHLMAR, A. (World Health Organization (WHO)) [WHO IUD supplies] Personal communication, Jul. 23, 1987.

257. NILSSON, C.G., LAHTEENMÄKI, P.L.A., and LUUKKAINEN, T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. Fertility and Sterility 41(1): 52–55. Jan. 1984.

258. NILSSON, C.G., LUUKKAINEN, T., DIAZ, J., and ALLONEN, H. Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study. Lancet 1(8220): 577–580. Mar. 14, 1981.

259. NORTMAN, D.L. Population and family planning programs: a compendium of data through 1983. 12th ed. New York, Population Council, 1985. 58 p.

* 260. ORTIZ, M.E. and CROXATTO, H.B. The mode of action of IUDs. Contraception 36(1): 37–53. Jul. 1987.

261. ORY, H.W. and WOMEN’S HEALTH STUDY. Ectopic pregnancy and intrauterine contraceptive devices: new perspectives. Obstetrics and Gynecology 57(2): 137–144. Feb. 1981.

262. ORY, H.W., FORREST, J.D., and LINCOLN, R. Making choices: evaluating the health risks and benefits of birth control methods. New York, Alan Guttmacher Institute, 1983. 72 p.

263. OSLER, M. (Foreningen for Familieplanlægning) [IUD use in Denmark] Personal communication, Jun. 17, 1987.

264. OSTER, G.K. Chemical reactions of the copper intrauterine device. Fertility and Sterility 23(1): 18–23. Jan. 1972.

265. PAAVONEN, J. and VESTERINEN, E. Intrauterine contraceptive device use in patients with acute salpingitis. Contraception 22(2): 107–114. Aug. 1980.

266. PAKISTAN. MINISTRY OF PLANNING AND DEVELOPMENT (MPD). POPULATION WELFARE DIVISION. Pakistan contraceptive prevalence survey: 1984–85. Islamabad, Pakistan, MPD, Oct. 1986. 101 p.

267. PARDTHAISONG, T. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis. Journal of Biosocial Science 16(1): 23–34. 1984.

268. PASTENE, L., RIVERA, M., ZIPPER, J., MEDEL, M., and THOMAS, M. IUD insertions by midwives: five years’ experience in Santiago, Chile. International Journal of Gynaecology and Obstetrics 15: 84–87. 1977.

* 269. PATHFINDER FUND. Intrauterine devices. Rev. In: Health provider’s guide to contraception. [Draft] [1987] 38 p.

270. PAXMAN, J. (Pathfinder Fund) [Role of nurses and midwives in IUD services] Personal communication, Oct. 5, 1987.

271. PEDRÓN, N., GALLEGOS, A.J., LOZANO, M., and AZNAR, R. Menstrual blood loss estimates in women using Copper 7 and Multiload-250 intrauterine devices. Contraception 26(5): 475–485. Nov. 1982.

272. PEREZ, A.E. and CABIGON, J.V. Contraceptive practice in the Philippines: a synthesis. Philippine Population Journal 1(1): 36–57. Mar. 1985.

273. PIOTROW, P.T., RINEHART, W., and SCHMIDT, J.C. IUDs—update on safety, effectiveness, and research. Population Reports, Series B, No. 3. Baltimore, Johns Hopkins University, Population Information Program, May 1979. 52 p.

274. PLANNED PARENTHOOD FEDERATION OF AMERICA (PPFA). Draft minutes of PPFA convened expert panel on the future of the IUD. [Memorandum] New York, PPFA, Feb. 14, 1986. 14 p. (Mimeo)

275. PLANNED PARENTHOOD FEDERATION of AMERICA. Draft minutes of the National Medical Committee Meeting, May 2–3, 1987, San Mateo, California. Jul. 2, 1987.

276. POLAND, B.J., MILLER, J.R., HARRIS, M., and LIVINGSTON, J. Spontaneous abortion. Acta Obstetricia et Gynecologica Scandinavica (Suppl. 102): 1–32. 1981.

277. POMA, P.A. Intrauterine contraception and tubal pathology. International Journal of Fertility 25(4): 287–292. 1980.

278. POMEROY, R. (Family Planning International Assistance (FPIA)) [FPIA IUD supplies, 1982–87] Personal communication, Nov. 19, 1987.

279. POPULATION COUNCIL (PC). Five intrauterine devices for public programs. [Booklet] New York, PC, Nov. 1979. 17 p.

280. POPULATION COUNCIL (PC). The Population Council 1985 annual report. New York, PC, 1985. 92 p.

281. POPULATION COUNCIL. Cleaning surgical instruments. Norplant Worldwide, No. 8. Aug. 1987. p. 3.

282. POPULATION COUNCIL. Memorandum from the Population Council concerning the international availability of Copper T IUDs. New York, Population Council, Feb. 4, 1986. 2 p.

283. PORTER, C.W., Jr. Prevention of infection in voluntary surgical contraception. Biomedical Bulletin 6(1): 1–7. Mar. 1987.

284. PREMA, K. Haemoglobin levels in contraceptive users. Indian Journal of Medical Research 69: 756–760. May 1979.

285. PROGRAM FOR INTERNATIONAL TRAINING IN HEALTH (INTRAH). Semi annual report number six: Apr. 1, 1987-Sep. 30, 1987. Chapel Hill, North Carolina, INTRAH, 1987. 206 p.

286. PROGRAM FOR INTERNATIONAL TRAINING IN HEALTH (INTRAH). Semi-annual report number five: Oct. 1, 1986-Mar. 31, 1987. Chapel Hill, North Carolina, INTRAH, 1987. 179 p.

287. PROGRAM FOR INTERNATIONAL TRAINING IN HEALTH (INTRAH). Trip report, Nigeria, Apr. 15 to May 25, 1986. Chapel Hill, North Carolina, INTRAH, 1986. 22 p.

288. PROGRAM FOR THE INTRODUCTION AND ADAPTATION OF CONTRACEPTIVE TECHNOLOGY. [Descriptions of three IUD projects in China] [1984]. 2 p. (Unpublished)

289. PROGRAM FOR THE INTRODUCTION AND ADAPTATION OF CONTRACEPTIVE TECHNOLOGY. Contraceptive use in China. 1986. 8 p. (Unpublished)

* 290. PROGRAM FOR THE INTRODUCTION AND ADAPTATION OF CONTRACEPTIVE TECHNOLOGY. The Copper T 380 IUD: a manual for clinicians. [Booklet] New York, Population Council, Jan. 1985. 20 p.

291. PYÖRÄLÄ, T., ALLONEN, H., NYGREN, K.-G., NIELSEN, N.-C., and LUUKKAINEN, T. Return of fertility after the removal of Nova T or Copper T 200. Contraception 26(2): 113–120. Aug. 1982.

* 292. RAMIREZ, F.J. and STARRS, A.M. The ending of IUD sales in the United States: what are the international implications? International Family Planning Perspectives 13(2): 71–74. Jun. 1987.

293. RAMOS, R. and APELO, R.A. A program of IUD insertions by paraprofessionals and physicians in the Philippines. International Journal of Gynaecology and Obstetrics 16(4): 321–323. Jan.-Feb. 1979.

294. RANDIC, L., VLASIC, S., MATRLJAN, I., and WASZAK, C.S. Return to fertility after IUD removal for planned pregnancy. Contraception 32(3): 253–259. Sep. 1985.

295. REHMER, L.W. (Department of Health and Welfare, Health Information Division, Ottawa, Canada) [IUD use in Canada] Personal communication, Jun. 17, 1987.

296. RIOUX, J.-E., CLOUTIER, D., DUPONT, P., and LAMONDE, D. Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices. Canadian Medical Association Journal 134(7): 747–751. Apr. 1, 1986.

297. RIPHAGEN, F.E., VAN DER VURST, J., and LEHERT, P. Contraception in France. Geneva, International Health Foundation, 1985. 60 p.

298. RIVERA, R., ALMONTE, H., ARREOLA, M., LOPEZ, F., MONARREZ, G., NAVARRO, C., ORTIZ, E., PERKIN, G.W., and RUIZ, R. The use of different hormonal contraceptives and IUDs in anemic women: a six-month follow-up. Advances in Planned Parenthood 15(2): 56–63. 1980.

299. ROBERTSON, E.M. Is the malpractice crisis filtering down to family planning? Contraceptive Technology Update 7(6): 61–64. Jun. 1986.

300. ROBERTSON, E.M., ed. Proceed with caution during difficult IUD insertion. Contraceptive Technology Update 9(3): 25–28. Mar. 1988.

Population Reports is published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA